OR WAIT 15 SECS
Certara has unveiled the formation of a new product development innovation practice area that will be focused on global health.
In a July 9, 2019 press release, Certara has unveiled the formation of a new product development innovation practice area that will be focused on global health, Certara Global Health (CGH).
The new area will leverage the company’s cross-functional, interdisciplinary global scientific staff to provide innovation across a variety of areas. For example, CGH will utilize new development methodologies, regulatory science approaches, and talent, among other things, to accelerate health equity for the global population.
“CGH will bring together talent, technology, software, systems, and processes to accelerate the development of medicines for those that need them most,” said Craig Rayner, SVP and co-Lead of CGH. “Working closely with the foundation and other leaders in the global health sector, CGH will focus on creating novel and impactful drug development, regulatory science, and patient access approaches that will deliver effective and affordable therapies to populations in need around the world. A triple bottom line practice across the global health product development ecosystem.”
“Developing medicines is expensive and difficult at the best of times, and securing talent and capital is an extra challenge for the global health sector,” said Kevin Hershberger, VP and co-Lead of CGH. “But we are confident that we can play a catalytic role in bringing creative thinkers together with leading-edge technologies and methodologies, to support solving medicine development and access challenges in global health.”